Snowden Capital Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,165
Closed -$93.3K 1256
2024
Q3
$93.3K Buy
+14,165
New +$93.3K ﹤0.01% 1197